Skip to main content

Table 2 Survival estimate of patients in the TRT and non-TRT group

From: Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis

Survival estimated

TRT Group

(n = 99)

non-TRT Group

(n = 98)

P value

1-year PFS, %

41.9

30.6

0.030

1-year OS, %

78.2

64.8

0.033

2-year OS, %

41.5

24.5

0.019

  1. PFS, progression-free survival; OS, overall survival; TRT, thoracic radiotherapy
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us